VILIN BIO MED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.15 INR | -3.53% |
|
+0.79% | -17.81% |
| May. 29 | Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director | CI |
| May. 29 | Vilin Bio Med Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Sales 2022 | 112M 1.34M | Sales 2023 | 123M 1.48M | Capitalization | 267M 3.2M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | 12M 144K | EV / Sales 2022 * | - |
| Net cash position 2022 * | - 0 | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | - |
| Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.53% | ||
| 1 week | +0.79% | ||
| Current month | +0.79% | ||
| 3 months | -4.25% | ||
| 6 months | -13.93% | ||
| Current year | -17.81% |
1 week
18.85
20.40
1 month
16.0021.25
Current year
16.0030.45
1 year
16.0030.45
3 years
16.0030.45
5 years
16.0030.45
10 years
16.0030.45
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 21-11-30 | |
Srikanth Chilam
DFI | Director of Finance/CFO | 44 | 22-12-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 21-11-30 | |
| Chief Executive Officer | 58 | 21-11-30 | |
| Chairman | 56 | 23-01-03 |
Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -17.81% | 3.2M | |
| +51.63% | 796B | |
| +41.51% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.66% | 244B | |
| +3.39% | 228B | |
| +10.75% | 214B | |
| +6.99% | 165B |
- Stock Market
- Equities
- VILINBIO Stock
